@article{d88dd2e43bb74f7f9b29e43add2063c9,
title = "The impact of genetic counselors{\textquoteright} use of facilitative strategies on cognitive and emotional processing of genetic risk disclosure for Alzheimer's disease",
abstract = "Objectives: To determine the impact of genetic counselor (GC) communication on cognitive and emotional processing of Alzheimer's disease (AD) risk information during discussions with patients with clinical diagnoses of mild cognitive impairment and their companion. Methods: 79 recordings and transcripts of AD risk disclosure sessions collected as part of the fourth REVEAL Trial were coded using the Roter Interaction Analysis System (RIAS) and the Linguistic Inquiry Word Count (LIWC). Multilevel analyses were used to determine the association between GCs{\textquoteright} use of communication facilitation strategies and patient and companion use of words indicative of cognitive and emotional processing. Results: GC used somewhat more cognitive (14%) than emotional (10%) facilitation strategies. Both patients and companions used more words indicative of cognitive (18% and 17%) than emotional (6% and 5%) processing. GC use of facilitative strategies and patient and companion use of cognitive and emotional processing words were significantly associated in both unadjusted and adjusted models (all p-values < 0.01). Conclusions: GCs{\textquoteright} use of facilitative strategies assist in cognitive and emotional processing in a way that may be linked to therapeutic benefit. Practice implications: These findings highlight mechanisms through which GCs may assist patients and companions to better understand and cope with risk information.",
keywords = "Alzheimer's disease, Genetic counseling, Genetic testing, Patient–provider communication, Social cognitive processing, Visit companion",
author = "Yue Guan and Roter, {Debra L.} and Wolff, {Jennifer L.} and Gitlin, {Laura N} and Christensen, {Kurt D.} and Roberts, {J. Scott} and Green, {Robert C.} and Erby, {Lori Ann Hamby}",
note = "Funding Information: This work was supported by NIH grants HG002213, HG006500, HD077671, AG013846, RR000533, RR010284, TR001102, AG053760, and HG009173. Additional members of the REVEAL Study Group are Deborah Blacker, Massachusetts General Hospital/Harvard Medical School and Harvard School of Public Health, Boston, Massachusetts; Melissa Butson, Case Western Reserve University, Cleveland, Ohio; Clara Chen, Boston University School of Public Health, Boston, Massachusetts; Robert Cook-Deegan, Sanford School of Public Policy, Durham, North Carolina; Elana Cox, Weill Cornell Medical College, New York, New York; L. Adrienne Cupples, Boston University School of Public Health, Boston, Massachusetts; Jessica Davis, Weill Cornell Medical College, New York, New York; Lindsay Farrer, Boston University School of Medicine and Boston University School of Public Health, Boston, Massachusetts; Grace-Ann Fasaye, Walter Reed National Military Medical Center, Bethesda, Maryland; Patrick Griffith, Morehouse School of Medicine, Atlanta, Georgia; Kristin Harkins, Perelman School of Medicine, Philadelphia, Pennsylvania; Susan Hiraki, GeneDX, Gaithersburg, Maryland; Megan Johnson, Howard University, Washington, DC; Stephanie Johnson, Howard University, Washington, DC; Jason Karlawish, Perelman School of Medicine, Philadelphia, Pennsylvania; Denise Perry, Brigham and Women's Hospital, Boston, Massachusetts; Lan Le, University of Michigan School of Public Health, Ann Arbor, Michigan; Elana Levison, Division of Genetics, New York Presbyterian Hospital, New York, New York; Natalie Bartnik, University of Michigan School of Public Health, Ann Arbor, Michigan); Erin Linnenbringer, Washington University School of Medicine, St. Louis, Missouri; Elisabeth McCarty Wood, Perelman School of Medicine, Philadelphia, Pennsylvania; Thomas Obisesan, Howard University Hospital, Washington, DC; Stephen Post, Stony Brook University, Stony Brook, New York; Kimberly Quaid, Indiana University School of Medicine, Indianapolis, Indiana; Lisa Ravdin, Weill Cornell Medical College, New York, New York; Norman Relkin, Weill Medical College of Cornell University, New York, New York; Charmaine Royal, Duke University, Durham, North Carolina; Robert Stern, Boston University School of Medicine, Boston, Massachusetts; A. Dessa Sadovnick, University of British Columbia, Vancouver, British Columbia; Susan Sami, Case Western Reserve University, Cleveland, Ohio; Pamela Sankar, Perelman School of Medicine, Philadelphia, Pennsylvania; Wendy Uhlmann, University of Michigan Medical School, Ann Arbor, Michigan; Leo Waterston, Brigham and Women's Hospital, Boston, Massachusetts; Peter Whitehouse, Case Western Reserve University, Cleveland, Ohio; and Lori Wright, Medical College of Georgia, Athens, Georgia. Funding Information: This work was supported by NIH grants HG002213 , HG006500 , HD077671 , AG013846 , RR000533 , RR010284 , TR001102 , AG053760, and HG009173 . Additional members of the REVEAL Study Group are Deborah Blacker, Massachusetts General Hospital/Harvard Medical School and Harvard School of Public Health, Boston, Massachusetts; Melissa Butson, Case Western Reserve University, Cleveland, Ohio; Clara Chen, Boston University School of Public Health, Boston, Massachusetts; Robert Cook-Deegan, Sanford School of Public Policy, Durham, North Carolina; Elana Cox, Weill Cornell Medical College, New York, New York; L. Adrienne Cupples, Boston University School of Public Health, Boston, Massachusetts; Jessica Davis, Weill Cornell Medical College, New York, New York; Lindsay Farrer, Boston University School of Medicine and Boston University School of Public Health, Boston, Massachusetts; Grace-Ann Fasaye, Walter Reed National Military Medical Center, Bethesda, Maryland; Patrick Griffith, Morehouse School of Medicine, Atlanta, Georgia; Kristin Harkins, Perelman School of Medicine, Philadelphia, Pennsylvania; Susan Hiraki, GeneDX, Gaithersburg, Maryland; Megan Johnson, Howard University, Washington, DC; Stephanie Johnson, Howard University, Washington, DC; Jason Karlawish, Perelman School of Medicine, Philadelphia, Pennsylvania; Denise Perry, Brigham and Women{\textquoteright}s Hospital, Boston, Massachusetts; Lan Le, University of Michigan School of Public Health, Ann Arbor, Michigan; Elana Levison, Division of Genetics, New York Presbyterian Hospital, New York, New York; Natalie Bartnik, University of Michigan School of Public Health, Ann Arbor, Michigan); Erin Linnenbringer, Washington University School of Medicine, St. Louis, Missouri; Elisabeth McCarty Wood, Perelman School of Medicine, Philadelphia, Pennsylvania; Thomas Obisesan, Howard University Hospital, Washington, DC; Stephen Post, Stony Brook University, Stony Brook, New York; Kimberly Quaid, Indiana University School of Medicine, Indianapolis, Indiana; Lisa Ravdin, Weill Cornell Medical College, New York, New York; Norman Relkin, Weill Medical College of Cornell University, New York, New York; Charmaine Royal, Duke University, Durham, North Carolina; Robert Stern, Boston University School of Medicine, Boston, Massachusetts; A. Dessa Sadovnick, University of British Columbia, Vancouver, British Columbia; Susan Sami, Case Western Reserve University, Cleveland, Ohio; Pamela Sankar, Perelman School of Medicine, Philadelphia, Pennsylvania; Wendy Uhlmann, University of Michigan Medical School, Ann Arbor, Michigan; Leo Waterston, Brigham and Women{\textquoteright}s Hospital, Boston, Massachusetts; Peter Whitehouse, Case Western Reserve University, Cleveland, Ohio; and Lori Wright, Medical College of Georgia, Athens, Georgia. Publisher Copyright: {\textcopyright} 2017 Elsevier B.V.",
year = "2018",
month = may,
doi = "10.1016/j.pec.2017.11.019",
language = "English (US)",
volume = "101",
pages = "817--823",
journal = "Patient Education and Counseling",
issn = "0738-3991",
publisher = "Elsevier Ireland Ltd",
number = "5",
}